- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1755-1536
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Activation of hepatic stellate cell in Pten null liver injury model ; volume:9 ; number:1 ; day:14 ; month:6 ; year:2016 ; pages:1-13 ; date:12.2016
Fibrogenesis & tissue repair ; 9, Heft 1 (14.6.2016), 1-13, 12.2016
- Urheber
-
He, Lina
- Beteiligte Personen und Organisationen
-
Gubbins, James
Peng, Zhechu
Medina, Vivian
Fei, Fan
Asahina, Kinji
Wang, Jiaohong
Kahn, Michael
Rountree, Carl B.
Stiles, Bangyan L.
SpringerLink (Online service)
- DOI
-
10.1186/s13069-016-0045-1
- URN
-
urn:nbn:de:1111-201606171535
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- He, Lina
- Gubbins, James
- Peng, Zhechu
- Medina, Vivian
- Fei, Fan
- Asahina, Kinji
- Wang, Jiaohong
- Kahn, Michael
- Rountree, Carl B.
- Stiles, Bangyan L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Epigenetic regulation during hepatic stellate cell activation
Mitochondrial uncouplers inhibit hepatic stellate cell activation
Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Transcriptional regulation of Hepatic Stellate Cell activation in NASH
Kindlin-2 regulates hepatic stellate cells activation and liver fibrogenesis
Toll-like receptor 5 tunes hepatic and pancreatic stellate cells activation
Hepatic stellate cells: central modulators of hepatic carcinogenesis
Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression
EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells
Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells
miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression
Epigenetic regulation during hepatic stellate cell activation
Mitochondrial uncouplers inhibit hepatic stellate cell activation
Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Transcriptional regulation of Hepatic Stellate Cell activation in NASH
Kindlin-2 regulates hepatic stellate cells activation and liver fibrogenesis
Toll-like receptor 5 tunes hepatic and pancreatic stellate cells activation
Hepatic stellate cells: central modulators of hepatic carcinogenesis
Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression
EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells
Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells
miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression
Epigenetic regulation during hepatic stellate cell activation
Mitochondrial uncouplers inhibit hepatic stellate cell activation
Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Transcriptional regulation of Hepatic Stellate Cell activation in NASH
Kindlin-2 regulates hepatic stellate cells activation and liver fibrogenesis
Toll-like receptor 5 tunes hepatic and pancreatic stellate cells activation
Hepatic stellate cells: central modulators of hepatic carcinogenesis
Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression
EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells
Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells